clinical trials

Travere’s Kidney Disease Drug Narrowly Misses Phase III Endpoint, Stock Tanks
Travere’s Kidney Disease Drug Narrowly Misses Phase III Endpoint, Stock Tanks
BioSpace
Travere Therapeutics
kidney disease
sparsentan
Filspari
clinical trials
Flag link:
Pain points: Unsolved recruitment and trial design issues in pain clinical trials
Pain points: Unsolved recruitment and trial design issues in pain clinical trials
Clinical Trials Arena
clinical trials
chronic pain
painkillers
Flag link:
1ST Biotherapeutics and Merck to assess cancer combination treatment
1ST Biotherapeutics and Merck to assess cancer combination treatment
Clinical Trials Arena
Merck
1st Biotherapeutics
Keytruda
solid tumors
clinical trials
Flag link:
Medidata unveils new solution to boost clinical trial diversity
Medidata unveils new solution to boost clinical trial diversity
Clinical Trials Arena
Medidata
clinical trials
clinical trial diversity
Flag link:
FDA's single-trial guidance calls for the good, bad and ugly data to support effectiveness
FDA's single-trial guidance calls for the good, bad and ugly data to support effectiveness
Fierce Biotech
FDA
clinical trials
regulatory
Flag link:
Elon Musk’s Neuralink announces it will start human trials for brain implant
Elon Musk’s Neuralink announces it will start human trials for brain implant
Medical Marketing and Media
Neuralink
spinal cord injury
clinical trials
Elon Musk
Flag link:
Guard argues new data render primary endpoint miss 'irrelevant,' tripling share price
Guard argues new data render primary endpoint miss 'irrelevant,' tripling share price
Fierce Biotech
Guard Therapeutics
kidney injury
clinical trials
RMC-035
Flag link:
Iveric Bio Announces Positive 24-Month Topline Results from Phase 3 Study of Izervay for Geographic Atrophy
Iveric Bio Announces Positive 24-Month Topline Results from Phase 3 Study of Izervay for Geographic Atrophy
PR Newswire
Astellas
clinical trials
Izervay
geographic atrophy
Flag link:
Pfizer's 'entrenched' tafamidis franchise will be tough to challenge for Alnylam, BridgeBio: analysts
Pfizer's 'entrenched' tafamidis franchise will be tough to challenge for Alnylam, BridgeBio: analysts
Fierce Pharma
Pfizer
BridgeBio
Alnylam
FDA
clinical trials
ATTR-CM
physicians
tafamidis
Flag link:
BioMarin's share prices fluctuate following Phase 3 clinical trial results
BioMarin's share prices fluctuate following Phase 3 clinical trial results
Yahoo/Investing.com
Biomarin
Roctavian
clinical trials
Flag link:
Cassava Sciences Announces Positive Interim Safety Review of Simufilam On-going Phase 3 Trials in Patients with Alzheimer’s Disease
Cassava Sciences Announces Positive Interim Safety Review of Simufilam On-going Phase 3 Trials in Patients with Alzheimer’s Disease
BioSpace
Cassava Sciences
clinical trials
Simulfilam
Alzheimer's disease
Flag link:
Anthos hails win over Xarelto with novel anticoagulant
Anthos hails win over Xarelto with novel anticoagulant
Pharmaphorum
Anthos Therapeutics
clinical trials
abelacimab
Xarelto
anticoagulants
atrial fibrillation
Flag link:
Kite publishes Phase II data for Yescarta in treating B-cell lymphoma
Kite publishes Phase II data for Yescarta in treating B-cell lymphoma
Clinical Trials Arena
Gilead Sciences
Kite Pharma
Yescarta
clinical trials
CAR-T
relapsed or refractory large B-cell lymphoma
Flag link:
NIH begins human trials of 'universal' flu vaccine
NIH begins human trials of 'universal' flu vaccine
Yahoo/Reuters
NIH
clinical trials
vaccines
universal flu vaccine
FluMos-v2
Flag link:
MDMA approval filing nears after drug hits again in phase 3, showing consistent PTSD improvements
MDMA approval filing nears after drug hits again in phase 3, showing consistent PTSD improvements
Fierce Biotech
MDMA
MAPS Public Benefit Corp
clinical trials
PTSD
psychedelic drugs
Flag link:
Anavex’s Blarcamesine Slows Cognitive Decline in Alzheimer’s Patients
Anavex’s Blarcamesine Slows Cognitive Decline in Alzheimer’s Patients
BioSpace
Anavex
Alzheimer's disease
blarcamesine
clinical trials
Flag link:
Why Shares of Tango Therapeutics Climbed This Week
Why Shares of Tango Therapeutics Climbed This Week
Motley Fool
Tango Therapeutics
CRISPR
gene editing
clinical trials
Flag link:
Bristol Myers plans to double experimental treatments to expand research pipeline
Bristol Myers plans to double experimental treatments to expand research pipeline
Yahoo/Reuters
Bristol Myers Squibb
clinical trials
R&D
Flag link:
Moderna says flu vaccine showed promising results in phase three trial, paving path to approval
Moderna says flu vaccine showed promising results in phase three trial, paving path to approval
CNBC
Moderna Therapeutics
vaccines
Flu
flu vaccines
clinical trials
Flag link:
AbbVie’s Skyrizi Outperforms J&J’s Stelara in Late-Stage Crohn’s Disease Trial
AbbVie’s Skyrizi Outperforms J&J’s Stelara in Late-Stage Crohn’s Disease Trial
BioSpace
AbbVie
Skyrizi
JNJ
Stelara
Crohn's Disease
clinical trials
Flag link:

Pages